Ki-67 and Her2 expression | Overall cancer | Node-negative cancer | Node-positive cancer | |||
---|---|---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |
Univariable testa | ||||||
 Her2 negative and Ki-67 negative | 1 (reference) |  | 1 (reference) |  | 1 (reference) |  |
 Her2 negative and Ki-67 positive | 0.70 (0.38–1.30) | 0.500 | 0.11 (0.02–0.54) | 0.009 | 0.99 (0.45–2.17) | 0.109 |
 Her2 positive and Ki-67 negative | 0.43 (0.17–1.06) | 0.233 | 0.13 (0.02–0.84) | 0.033 | 0.48 (0.14–1.59) | 0.445 |
 Her2 positive and Ki-67 positive | 0.48 (0.22–1.05) | 0.337 | 0.14 (0.02–0.83) | 0.038 | 0.39 (0.15–1.05) | 0.122 |
Multivariable testb | ||||||
 Her2 negative and Ki-67 negative | 1 (reference) |  | 1 (reference) |  | 1 (reference) |  |
 Her2 negative and Ki-67 positive | 0.84 (0.44–1.60) | 0.807 | 0.07 (0.01–0.56) | 0.025 | 1.27 (0.55–2.94) | 0.126 |
 Her2 positive and Ki-67 negative | 0.64 (0.24–1.70) | 0.508 | 0.05 (< 0.01–0.69) | 0.030 | 0.66 (0.17–2.55) | 0.632 |
 Her2 positive and Ki-67 positive | 0.76 (0.33–1.75) | 0.838 | 0.06 (0.01–0.63) | 0.026 | 0.55 (0.19–1.63) | 0.266 |